These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23287897)

  • 1. Lectin-based immunoassay for aberrant IgG glycosylation as the biomarker for Crohn's disease.
    Shinzaki S; Kuroki E; Iijima H; Tatsunaka N; Ishii M; Fujii H; Kamada Y; Kobayashi T; Shibukawa N; Inoue T; Tsujii M; Takeishi S; Mizushima T; Ogata A; Naka T; Plevy SE; Takehara T; Miyoshi E
    Inflamm Bowel Dis; 2013 Feb; 19(2):321-31. PubMed ID: 23287897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of agalactosyl IgG in inflammatory bowel disease patients.
    Nakajima S; Iijima H; Shinzaki S; Egawa S; Inoue T; Mukai A; Hayashi Y; Kondo J; Akasaka T; Nishida T; Kanto T; Morii E; Mizushima T; Miyoshi E; Tsujii M; Hayashi N
    Inflamm Bowel Dis; 2011 Apr; 17(4):927-36. PubMed ID: 20824817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel disease.
    Shinzaki S; Iijima H; Nakagawa T; Egawa S; Nakajima S; Ishii S; Irie T; Kakiuchi Y; Nishida T; Yasumaru M; Kanto T; Tsujii M; Tsuji S; Mizushima T; Yoshihara H; Kondo A; Miyoshi E; Hayashi N
    Am J Gastroenterol; 2008 May; 103(5):1173-81. PubMed ID: 18177457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lectin-reactive anti-α-gal in patients with Crohn's disease: correlation with clinical phenotypes.
    Safaie P; Ham M; Kuang P; Mehta AS; Wang M; Cheifetz AS; Robson S; Lau D; Block TM; Moss AC
    Inflamm Bowel Dis; 2013 Dec; 19(13):2796-800. PubMed ID: 24185312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of N-acetylgalactosamine in O-linked oligosaccharides of IgA is a novel biologic marker for Crohn's disease.
    Inoue T; Iijima H; Tajiri M; Shinzaki S; Shiraishi E; Hiyama S; Mukai A; Nakajima S; Iwatani H; Nishida T; Mizushima T; Yasui T; Isaka Y; Kanto T; Tsujii M; Miyoshi E; Wada Y; Takehara T
    Inflamm Bowel Dis; 2012 Sep; 18(9):1723-34. PubMed ID: 22241690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus.
    Sjöwall C; Zapf J; von Löhneysen S; Magorivska I; Biermann M; Janko C; Winkler S; Bilyy R; Schett G; Herrmann M; Muñoz LE
    Lupus; 2015 May; 24(6):569-81. PubMed ID: 25389233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant glycosylation of the anti-Thomsen-Friedenreich glycotope immunoglobulin G in gastric cancer patients.
    Kodar K; Izotova J; Klaamas K; Sergeyev B; Järvekülg L; Kurtenkov O
    World J Gastroenterol; 2013 Jun; 19(23):3573-82. PubMed ID: 23801858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases.
    Šimurina M; de Haan N; Vučković F; Kennedy NA; Štambuk J; Falck D; Trbojević-Akmačić I; Clerc F; Razdorov G; Khon A; Latiano A; D'Incà R; Danese S; Targan S; Landers C; Dubinsky M; ; McGovern DPB; Annese V; Wuhrer M; Lauc G
    Gastroenterology; 2018 Apr; 154(5):1320-1333.e10. PubMed ID: 29309774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
    Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
    World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Anti-glycan Antibodies and Inflammatory Bowel Disease Course.
    Paul S; Boschetti G; Rinaudo-Gaujous M; Moreau A; Del Tedesco E; Bonneau J; Presles E; Mounsef F; Clavel L; Genin C; Flourié B; Phelip JM; Nancey S; Roblin X
    J Crohns Colitis; 2015 Jun; 9(6):445-51. PubMed ID: 25895876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-food and anti-microbial IgG subclass antibodies in inflammatory bowel disease.
    Jansen A; Mandić AD; Bennek E; Frehn L; Verdier J; Tebrügge I; Lutz H; Streetz K; Trautwein C; Sellge G
    Scand J Gastroenterol; 2016 Dec; 51(12):1453-1461. PubMed ID: 27455092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
    Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein.
    Dubé R; Rook GA; Steele J; Brealey R; Dwek R; Rademacher T; Lennard-Jones J
    Gut; 1990 Apr; 31(4):431-4. PubMed ID: 2338269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of five techniques to detect anti-Saccharomyces cerevisiae antibodies (ASCA) in serum for diagnosing Crohn's disease].
    Le Goff C; Chapelle JP; Lutteri L
    Ann Biol Clin (Paris); 2007; 65(6):601-8. PubMed ID: 18039604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimising the diagnostic value of anti-Saccharomyces cerevisiae-antibodies (ASCA) in Crohn's disease.
    Klebl FH; Bataille F; Hofstädter F; Herfarth H; Schölmerich J; Rogler G
    Int J Colorectal Dis; 2004 Jul; 19(4):319-24. PubMed ID: 14745572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low mannose-binding lectin (MBL) is associated with paediatric inflammatory bowel diseases and ileal involvement in patients with Crohn disease.
    Kovacs M; Papp M; Lakatos PL; Jacobsen S; Nemes E; Polgar M; Solyom E; Bodi P; Horvath A; Molnar K; Szabo D; Cseh A; Muller KE; Dezsofi A; Arato A; Veres G
    J Crohns Colitis; 2013 Mar; 7(2):134-41. PubMed ID: 22504031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn's disease.
    Roggenbuck D; Reinhold D; Wex T; Goihl A; von Arnim U; Malfertheiner P; Büttner T; Porstmann T; Porstmann S; Liedvogel B; Bogdanos DP; Laass MW; Conrad K
    Clin Chim Acta; 2011 Apr; 412(9-10):718-24. PubMed ID: 21195704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Food-specific IgGs Are Highly Increased in the Sera of Patients with Inflammatory Bowel Disease and Are Clinically Relevant to the Pathogenesis.
    Xiao N; Liu F; Zhou G; Sun M; Ai F; Liu Z
    Intern Med; 2018 Oct; 57(19):2787-2798. PubMed ID: 29780153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased titers of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients with reduced H-ficolin levels but normal MASP-2 activity.
    Schaffer T; Flogerzi B; Schoepfer AM; Seibold F; Müller S
    J Crohns Colitis; 2013 Feb; 7(1):e1-10. PubMed ID: 22445443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.